MycoMed Technologies I Products to Prevent Infection

Yearly Archives: 2018

/2018

MycoMed Receives Notice of Allowance for US Patent Application Pub. No. 20130017561

MycoMed is pleased to announce that the United States Patent and Trademark Office has issued a Notice of Allowance for US Patent Application Pub. No. 20130017561. The allowed claims relate to methods for the detection of Aspergillus fumigatus. US patent office issuance of application No.: 13/511,264 Title: LATERAL FLOW DEVICE FOR DIAGNOSING MICROBIAL INFECTIONS

By | 2019-02-22T17:57:43+00:00 September 1st, 2018|

MycoMed Publishes Paper in “Clinical Infectious Disease”

In April 2018, MycoMed Technologies published a paper in Clinical Infectious Disease titled: “Urine Antigen Detection as an Aid to Diagnose Invasive Aspergillosis”. MycoMed Technologies in collaboration with Johns Hopkins University published a paper in Clinical Infectious Diseases (CID) detailing an optimized lateral flow dipstick assay utilizing a galactofuranose-specific antibody (mAb476). This urine test showed promise [...]

By | 2019-02-22T16:54:49+00:00 April 18th, 2018|

MycoMed Technologies Awarded US Patent #9,915,657

On March 13, 2018 MycoMed Technologies was awarded US patent# 9,915,657 for a lateral flow device (LFD) for the detection of Aspergillus antigens in urine. Aspergillosis is a common infection in people with weakened immune systems, especially after transplantation or cancer therapy. This simple assay will allow for early detection to prevent severe disease. View [...]

By | 2018-03-21T16:46:52+00:00 March 13th, 2018|